Skip to main content

Are Wall Street Analysts Predicting Church & Dwight Stock Will Climb or Sink?

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Ewing, New Jersey-based Church & Dwight Co., Inc. (CHD) develops, manufactures, and markets household, personal care, and specialty products. Valued at $22.9 billion by market cap, the company offers contraceptive products, laundry and dishwashing detergents, toothbrushes, shampoos, vitamins, pregnancy test kits, and hair removers.

Shares of this leading U.S. producer of sodium bicarbonate have underperformed the broader market over the past year. CHD has declined marginally over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 23.3%. However, in 2026, CHD stock is up 14.2%, surpassing SPX’s 7.4% rise on a YTD basis.

 

Narrowing the focus, CHD’s underperformance is also apparent compared to the State Street Consumer Staples Select Sector SPDR ETF (XLP). The exchange-traded fund has gained about 4.6% over the past year. However, the stock’s gains on a YTD basis outshine the ETF’s 10.8% returns over the same time frame.

www.barchart.com

On May 1, CHD shares closed down more than 1% after reporting its Q1 results. Its adjusted EPS of $0.95 exceeded Wall Street expectations of $0.93. The company’s revenue was $1.5 billion, meeting Wall Street forecasts.

For the current fiscal year, ending in December, analysts expect CHD’s EPS to grow 6.5% to $3.76 on a diluted basis. The company’s earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters.

Among the 20 analysts covering CHD stock, the consensus is a “Moderate Buy.” That’s based on eight “Strong Buy” ratings, two “Moderate Buys,” nine “Holds,” and one “Strong Sell.”

www.barchart.com

The configuration has been consistent over the past months. 

On May 13, Nik Modi from RBC Capital maintained a “Buy” rating on CHD, with a price target of $114, implying a potential upside of 19.1% from current levels.

The mean price target of $103.78 represents an 8.4% premium to CHD’s current price levels. The Street-high price target of $115 suggests an upside potential of 20.1%.


On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  265.01
+5.67 (2.19%)
AAPL  302.25
+3.28 (1.10%)
AMD  447.58
+33.53 (8.10%)
BAC  51.23
+0.53 (1.05%)
GOOG  384.90
+0.00 (0.00%)
META  605.06
+2.45 (0.41%)
MSFT  421.06
+3.64 (0.87%)
NVDA  223.47
+2.86 (1.30%)
ORCL  188.16
+6.70 (3.69%)
TSLA  417.26
+13.15 (3.25%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.